Compile Data Set for Download or QSAR
Report error Found 150 Enz. Inhib. hit(s) with all data for entry = 10950
TargetATP-citrate synthase(Human)
Nimbus Artemis

US Patent
LigandPNGBDBM580509(US11492341, Compound I-24)
Affinity DataIC50: 500nMAssay Description:Compounds of the present invention were evaluated in an ADP-GLO assay as follows:a) Dilute cpd 1:3 in succession in DMSO by hand for each cpds for 12...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/20/2023
Entry Details
Go to US Patent

TargetATP-citrate synthase(Human)
Nimbus Artemis

US Patent
LigandPNGBDBM580519(US11492341, Compound I-34)
Affinity DataIC50: 500nMAssay Description:Compounds of the present invention were evaluated in an ADP-GLO assay as follows:a) Dilute cpd 1:3 in succession in DMSO by hand for each cpds for 12...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/20/2023
Entry Details
Go to US Patent

TargetATP-citrate synthase(Human)
Nimbus Artemis

US Patent
LigandPNGBDBM580530(US11492341, Compound I-44)
Affinity DataIC50: 500nMAssay Description:Compounds of the present invention were evaluated in an ADP-GLO assay as follows:a) Dilute cpd 1:3 in succession in DMSO by hand for each cpds for 12...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/20/2023
Entry Details
Go to US Patent

TargetATP-citrate synthase(Human)
Nimbus Artemis

US Patent
LigandPNGBDBM580560(US11492341, Compound I-55)
Affinity DataIC50: 500nMAssay Description:Compounds of the present invention were evaluated in an ADP-GLO assay as follows:a) Dilute cpd 1:3 in succession in DMSO by hand for each cpds for 12...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/20/2023
Entry Details
Go to US Patent

TargetATP-citrate synthase(Human)
Nimbus Artemis

US Patent
LigandPNGBDBM580567(US11492341, Compound I-62)
Affinity DataIC50: 500nMAssay Description:Compounds of the present invention were evaluated in an ADP-GLO assay as follows:a) Dilute cpd 1:3 in succession in DMSO by hand for each cpds for 12...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/20/2023
Entry Details
Go to US Patent

TargetATP-citrate synthase(Human)
Nimbus Artemis

US Patent
LigandPNGBDBM580654(US11492341, Compound I-159)
Affinity DataIC50: 500nMAssay Description:Compounds of the present invention were evaluated in an ADP-GLO assay as follows:a) Dilute cpd 1:3 in succession in DMSO by hand for each cpds for 12...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/20/2023
Entry Details
Go to US Patent

TargetATP-citrate synthase(Human)
Nimbus Artemis

US Patent
LigandPNGBDBM580457(US11492341, Compound I-1)
Affinity DataIC50: 1.03E+4nMAssay Description:Compounds of the present invention were evaluated in an ADP-GLO assay as follows:a) Dilute cpd 1:3 in succession in DMSO by hand for each cpds for 12...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/20/2023
Entry Details
Go to US Patent

TargetATP-citrate synthase(Human)
Nimbus Artemis

US Patent
LigandPNGBDBM580459(US11492341, Compound I-2)
Affinity DataIC50: 1.03E+4nMAssay Description:Compounds of the present invention were evaluated in an ADP-GLO assay as follows:a) Dilute cpd 1:3 in succession in DMSO by hand for each cpds for 12...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/20/2023
Entry Details
Go to US Patent

TargetATP-citrate synthase(Human)
Nimbus Artemis

US Patent
LigandPNGBDBM580461(US11492341, Compound I-3)
Affinity DataIC50: 1.03E+4nMAssay Description:Compounds of the present invention were evaluated in an ADP-GLO assay as follows:a) Dilute cpd 1:3 in succession in DMSO by hand for each cpds for 12...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/20/2023
Entry Details
Go to US Patent

TargetATP-citrate synthase(Human)
Nimbus Artemis

US Patent
LigandPNGBDBM580466(US11492341, Compound I-4)
Affinity DataIC50: 1.03E+4nMAssay Description:Compounds of the present invention were evaluated in an ADP-GLO assay as follows:a) Dilute cpd 1:3 in succession in DMSO by hand for each cpds for 12...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/20/2023
Entry Details
Go to US Patent

TargetATP-citrate synthase(Human)
Nimbus Artemis

US Patent
LigandPNGBDBM580468(US11492341, Compound I-5)
Affinity DataIC50: 1.03E+4nMAssay Description:Compounds of the present invention were evaluated in an ADP-GLO assay as follows:a) Dilute cpd 1:3 in succession in DMSO by hand for each cpds for 12...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/20/2023
Entry Details
Go to US Patent

TargetATP-citrate synthase(Human)
Nimbus Artemis

US Patent
LigandPNGBDBM580471(US11492341, Compound I-6)
Affinity DataIC50: 1.03E+4nMAssay Description:Compounds of the present invention were evaluated in an ADP-GLO assay as follows:a) Dilute cpd 1:3 in succession in DMSO by hand for each cpds for 12...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/20/2023
Entry Details
Go to US Patent

TargetATP-citrate synthase(Human)
Nimbus Artemis

US Patent
LigandPNGBDBM580472(US11492341, Compound I-7)
Affinity DataIC50: 1.03E+4nMAssay Description:Compounds of the present invention were evaluated in an ADP-GLO assay as follows:a) Dilute cpd 1:3 in succession in DMSO by hand for each cpds for 12...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/20/2023
Entry Details
Go to US Patent

TargetATP-citrate synthase(Human)
Nimbus Artemis

US Patent
LigandPNGBDBM580473(US11492341, Compound I-8)
Affinity DataIC50: 1.03E+4nMAssay Description:Compounds of the present invention were evaluated in an ADP-GLO assay as follows:a) Dilute cpd 1:3 in succession in DMSO by hand for each cpds for 12...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/20/2023
Entry Details
Go to US Patent

TargetATP-citrate synthase(Human)
Nimbus Artemis

US Patent
LigandPNGBDBM580478(US11492341, Compound I-9)
Affinity DataIC50: 1.03E+4nMAssay Description:Compounds of the present invention were evaluated in an ADP-GLO assay as follows:a) Dilute cpd 1:3 in succession in DMSO by hand for each cpds for 12...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/20/2023
Entry Details
Go to US Patent

TargetATP-citrate synthase(Human)
Nimbus Artemis

US Patent
LigandPNGBDBM580480(US11492341, Compound I-10)
Affinity DataIC50: 1.03E+4nMAssay Description:Compounds of the present invention were evaluated in an ADP-GLO assay as follows:a) Dilute cpd 1:3 in succession in DMSO by hand for each cpds for 12...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/20/2023
Entry Details
Go to US Patent

TargetATP-citrate synthase(Human)
Nimbus Artemis

US Patent
LigandPNGBDBM580483(US11492341, Compound I-11)
Affinity DataIC50: 1.03E+4nMAssay Description:Compounds of the present invention were evaluated in an ADP-GLO assay as follows:a) Dilute cpd 1:3 in succession in DMSO by hand for each cpds for 12...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/20/2023
Entry Details
Go to US Patent

TargetATP-citrate synthase(Human)
Nimbus Artemis

US Patent
LigandPNGBDBM580487(US11492341, Compound I-12)
Affinity DataIC50: 1.03E+4nMAssay Description:Compounds of the present invention were evaluated in an ADP-GLO assay as follows:a) Dilute cpd 1:3 in succession in DMSO by hand for each cpds for 12...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/20/2023
Entry Details
Go to US Patent

TargetATP-citrate synthase(Human)
Nimbus Artemis

US Patent
LigandPNGBDBM580489(US11492341, Compound I-13)
Affinity DataIC50: 1.03E+4nMAssay Description:Compounds of the present invention were evaluated in an ADP-GLO assay as follows:a) Dilute cpd 1:3 in succession in DMSO by hand for each cpds for 12...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/20/2023
Entry Details
Go to US Patent

TargetATP-citrate synthase(Human)
Nimbus Artemis

US Patent
LigandPNGBDBM580490(US11492341, Compound I-14)
Affinity DataIC50: 1.03E+4nMAssay Description:Compounds of the present invention were evaluated in an ADP-GLO assay as follows:a) Dilute cpd 1:3 in succession in DMSO by hand for each cpds for 12...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/20/2023
Entry Details
Go to US Patent

TargetATP-citrate synthase(Human)
Nimbus Artemis

US Patent
LigandPNGBDBM580492(US11492341, Compound I-15)
Affinity DataIC50: 1.03E+4nMAssay Description:Compounds of the present invention were evaluated in an ADP-GLO assay as follows:a) Dilute cpd 1:3 in succession in DMSO by hand for each cpds for 12...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/20/2023
Entry Details
Go to US Patent

TargetATP-citrate synthase(Human)
Nimbus Artemis

US Patent
LigandPNGBDBM580494(US11492341, Compound I-16)
Affinity DataIC50: 1.03E+4nMAssay Description:Compounds of the present invention were evaluated in an ADP-GLO assay as follows:a) Dilute cpd 1:3 in succession in DMSO by hand for each cpds for 12...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/20/2023
Entry Details
Go to US Patent

TargetATP-citrate synthase(Human)
Nimbus Artemis

US Patent
LigandPNGBDBM580497(US11492341, Compound I-17)
Affinity DataIC50: 1.03E+4nMAssay Description:Compounds of the present invention were evaluated in an ADP-GLO assay as follows:a) Dilute cpd 1:3 in succession in DMSO by hand for each cpds for 12...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/20/2023
Entry Details
Go to US Patent

TargetATP-citrate synthase(Human)
Nimbus Artemis

US Patent
LigandPNGBDBM580499(US11492341, Compound I-18)
Affinity DataIC50: 1.03E+4nMAssay Description:Compounds of the present invention were evaluated in an ADP-GLO assay as follows:a) Dilute cpd 1:3 in succession in DMSO by hand for each cpds for 12...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/20/2023
Entry Details
Go to US Patent

TargetATP-citrate synthase(Human)
Nimbus Artemis

US Patent
LigandPNGBDBM580500(US11492341, Compound I-19)
Affinity DataIC50: 1.03E+4nMAssay Description:Compounds of the present invention were evaluated in an ADP-GLO assay as follows:a) Dilute cpd 1:3 in succession in DMSO by hand for each cpds for 12...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/20/2023
Entry Details
Go to US Patent

TargetATP-citrate synthase(Human)
Nimbus Artemis

US Patent
LigandPNGBDBM580501(US11492341, Compound I-20)
Affinity DataIC50: 1.03E+4nMAssay Description:Compounds of the present invention were evaluated in an ADP-GLO assay as follows:a) Dilute cpd 1:3 in succession in DMSO by hand for each cpds for 12...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/20/2023
Entry Details
Go to US Patent

TargetATP-citrate synthase(Human)
Nimbus Artemis

US Patent
LigandPNGBDBM580502(US11492341, Compound I-21)
Affinity DataIC50: 1.03E+4nMAssay Description:Compounds of the present invention were evaluated in an ADP-GLO assay as follows:a) Dilute cpd 1:3 in succession in DMSO by hand for each cpds for 12...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/20/2023
Entry Details
Go to US Patent

TargetATP-citrate synthase(Human)
Nimbus Artemis

US Patent
LigandPNGBDBM580504(US11492341, Compound I-22)
Affinity DataIC50: 1.03E+4nMAssay Description:Compounds of the present invention were evaluated in an ADP-GLO assay as follows:a) Dilute cpd 1:3 in succession in DMSO by hand for each cpds for 12...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/20/2023
Entry Details
Go to US Patent

TargetATP-citrate synthase(Human)
Nimbus Artemis

US Patent
LigandPNGBDBM580506(US11492341, Compound I-23)
Affinity DataIC50: 1.03E+4nMAssay Description:Compounds of the present invention were evaluated in an ADP-GLO assay as follows:a) Dilute cpd 1:3 in succession in DMSO by hand for each cpds for 12...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/20/2023
Entry Details
Go to US Patent

TargetATP-citrate synthase(Human)
Nimbus Artemis

US Patent
LigandPNGBDBM580510(US11492341, Compound I-25)
Affinity DataIC50: 1.03E+4nMAssay Description:Compounds of the present invention were evaluated in an ADP-GLO assay as follows:a) Dilute cpd 1:3 in succession in DMSO by hand for each cpds for 12...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/20/2023
Entry Details
Go to US Patent

TargetATP-citrate synthase(Human)
Nimbus Artemis

US Patent
LigandPNGBDBM580511(US11492341, Compound I-26)
Affinity DataIC50: 1.03E+4nMAssay Description:Compounds of the present invention were evaluated in an ADP-GLO assay as follows:a) Dilute cpd 1:3 in succession in DMSO by hand for each cpds for 12...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/20/2023
Entry Details
Go to US Patent

TargetATP-citrate synthase(Human)
Nimbus Artemis

US Patent
LigandPNGBDBM580512(US11492341, Compound I-27)
Affinity DataIC50: 1.03E+4nMAssay Description:Compounds of the present invention were evaluated in an ADP-GLO assay as follows:a) Dilute cpd 1:3 in succession in DMSO by hand for each cpds for 12...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/20/2023
Entry Details
Go to US Patent

TargetATP-citrate synthase(Human)
Nimbus Artemis

US Patent
LigandPNGBDBM580513(US11492341, Compound I-28)
Affinity DataIC50: 1.03E+4nMAssay Description:Compounds of the present invention were evaluated in an ADP-GLO assay as follows:a) Dilute cpd 1:3 in succession in DMSO by hand for each cpds for 12...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/20/2023
Entry Details
Go to US Patent

TargetATP-citrate synthase(Human)
Nimbus Artemis

US Patent
LigandPNGBDBM580514(US11492341, Compound I-29)
Affinity DataIC50: 1.03E+4nMAssay Description:Compounds of the present invention were evaluated in an ADP-GLO assay as follows:a) Dilute cpd 1:3 in succession in DMSO by hand for each cpds for 12...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/20/2023
Entry Details
Go to US Patent

TargetATP-citrate synthase(Human)
Nimbus Artemis

US Patent
LigandPNGBDBM580515(US11492341, Compound I-30)
Affinity DataIC50: 1.03E+4nMAssay Description:Compounds of the present invention were evaluated in an ADP-GLO assay as follows:a) Dilute cpd 1:3 in succession in DMSO by hand for each cpds for 12...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/20/2023
Entry Details
Go to US Patent

TargetATP-citrate synthase(Human)
Nimbus Artemis

US Patent
LigandPNGBDBM580516(US11492341, Compound I-31)
Affinity DataIC50: 1.03E+4nMAssay Description:Compounds of the present invention were evaluated in an ADP-GLO assay as follows:a) Dilute cpd 1:3 in succession in DMSO by hand for each cpds for 12...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/20/2023
Entry Details
Go to US Patent

TargetATP-citrate synthase(Human)
Nimbus Artemis

US Patent
LigandPNGBDBM580517(US11492341, Compound I-32)
Affinity DataIC50: 1.03E+4nMAssay Description:Compounds of the present invention were evaluated in an ADP-GLO assay as follows:a) Dilute cpd 1:3 in succession in DMSO by hand for each cpds for 12...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/20/2023
Entry Details
Go to US Patent

TargetATP-citrate synthase(Human)
Nimbus Artemis

US Patent
LigandPNGBDBM580518(US11492341, Compound I-33)
Affinity DataIC50: 1.03E+4nMAssay Description:Compounds of the present invention were evaluated in an ADP-GLO assay as follows:a) Dilute cpd 1:3 in succession in DMSO by hand for each cpds for 12...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/20/2023
Entry Details
Go to US Patent

TargetATP-citrate synthase(Human)
Nimbus Artemis

US Patent
LigandPNGBDBM580520(US11492341, Compound I-35)
Affinity DataIC50: 1.03E+4nMAssay Description:Compounds of the present invention were evaluated in an ADP-GLO assay as follows:a) Dilute cpd 1:3 in succession in DMSO by hand for each cpds for 12...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/20/2023
Entry Details
Go to US Patent

TargetATP-citrate synthase(Human)
Nimbus Artemis

US Patent
LigandPNGBDBM580521(US11492341, Compound I-36)
Affinity DataIC50: 1.03E+4nMAssay Description:Compounds of the present invention were evaluated in an ADP-GLO assay as follows:a) Dilute cpd 1:3 in succession in DMSO by hand for each cpds for 12...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/20/2023
Entry Details
Go to US Patent

TargetATP-citrate synthase(Human)
Nimbus Artemis

US Patent
LigandPNGBDBM580522(US11492341, Compound I-37)
Affinity DataIC50: 1.03E+4nMAssay Description:Compounds of the present invention were evaluated in an ADP-GLO assay as follows:a) Dilute cpd 1:3 in succession in DMSO by hand for each cpds for 12...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/20/2023
Entry Details
Go to US Patent

TargetATP-citrate synthase(Human)
Nimbus Artemis

US Patent
LigandPNGBDBM580523(US11492341, Compound I-38)
Affinity DataIC50: 1.03E+4nMAssay Description:Compounds of the present invention were evaluated in an ADP-GLO assay as follows:a) Dilute cpd 1:3 in succession in DMSO by hand for each cpds for 12...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/20/2023
Entry Details
Go to US Patent

TargetATP-citrate synthase(Human)
Nimbus Artemis

US Patent
LigandPNGBDBM580524(US11492341, Compound I-39)
Affinity DataIC50: 1.03E+4nMAssay Description:Compounds of the present invention were evaluated in an ADP-GLO assay as follows:a) Dilute cpd 1:3 in succession in DMSO by hand for each cpds for 12...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/20/2023
Entry Details
Go to US Patent

TargetATP-citrate synthase(Human)
Nimbus Artemis

US Patent
LigandPNGBDBM580525(US11492341, Compound I-40)
Affinity DataIC50: 1.03E+4nMAssay Description:Compounds of the present invention were evaluated in an ADP-GLO assay as follows:a) Dilute cpd 1:3 in succession in DMSO by hand for each cpds for 12...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/20/2023
Entry Details
Go to US Patent

TargetATP-citrate synthase(Human)
Nimbus Artemis

US Patent
LigandPNGBDBM580526(US11492341, Compound I-41)
Affinity DataIC50: 1.03E+4nMAssay Description:Compounds of the present invention were evaluated in an ADP-GLO assay as follows:a) Dilute cpd 1:3 in succession in DMSO by hand for each cpds for 12...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/20/2023
Entry Details
Go to US Patent

TargetATP-citrate synthase(Human)
Nimbus Artemis

US Patent
LigandPNGBDBM580527(US11492341, Compound I-42)
Affinity DataIC50: 1.03E+4nMAssay Description:Compounds of the present invention were evaluated in an ADP-GLO assay as follows:a) Dilute cpd 1:3 in succession in DMSO by hand for each cpds for 12...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/20/2023
Entry Details
Go to US Patent

TargetATP-citrate synthase(Human)
Nimbus Artemis

US Patent
LigandPNGBDBM580529(US11492341, Compound I-43)
Affinity DataIC50: 1.03E+4nMAssay Description:Compounds of the present invention were evaluated in an ADP-GLO assay as follows:a) Dilute cpd 1:3 in succession in DMSO by hand for each cpds for 12...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/20/2023
Entry Details
Go to US Patent

TargetATP-citrate synthase(Human)
Nimbus Artemis

US Patent
LigandPNGBDBM580531(US11492341, Compound I-45)
Affinity DataIC50: 1.03E+4nMAssay Description:Compounds of the present invention were evaluated in an ADP-GLO assay as follows:a) Dilute cpd 1:3 in succession in DMSO by hand for each cpds for 12...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/20/2023
Entry Details
Go to US Patent

TargetATP-citrate synthase(Human)
Nimbus Artemis

US Patent
LigandPNGBDBM580533(US11492341, Compound I-46)
Affinity DataIC50: 1.03E+4nMAssay Description:Compounds of the present invention were evaluated in an ADP-GLO assay as follows:a) Dilute cpd 1:3 in succession in DMSO by hand for each cpds for 12...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/20/2023
Entry Details
Go to US Patent

TargetATP-citrate synthase(Human)
Nimbus Artemis

US Patent
LigandPNGBDBM580534(US11492341, Compound I-47)
Affinity DataIC50: 1.03E+4nMAssay Description:Compounds of the present invention were evaluated in an ADP-GLO assay as follows:a) Dilute cpd 1:3 in succession in DMSO by hand for each cpds for 12...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/20/2023
Entry Details
Go to US Patent

Displayed 1 to 50 (of 150 total ) | Next | Last >>
Jump to: